Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

NCT01888874 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

599

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: GLPG0634
DRUG: Placebo

Sponsor

Lakefront Biotherapeutics NV